These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30904169)

  • 21. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
    Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
    Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation changes that precede onset of dysplasia in advanced sessile serrated adenomas.
    Liu C; Fennell LJ; Bettington ML; Walker NI; Dwine J; Leggett BA; Whitehall VLJ
    Clin Epigenetics; 2019 Jun; 11(1):90. PubMed ID: 31200767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer.
    Ibrahim J; Op de Beeck K; Fransen E; Croes L; Beyens M; Suls A; Vanden Berghe W; Peeters M; Van Camp G
    Cancer Med; 2019 May; 8(5):2133-2145. PubMed ID: 30993897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation markers in colorectal cancer.
    Kim MS; Lee J; Sidransky D
    Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients.
    Takane K; Midorikawa Y; Yagi K; Sakai A; Aburatani H; Takayama T; Kaneda A
    Cancer Med; 2014 Oct; 3(5):1235-45. PubMed ID: 24861485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
    Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA.
    Ruiz-Bañobre J; Rodriguez-Casanova A; Costa-Fraga N; Bao-Caamano A; Alvarez-Castro A; Carreras-Presas M; Brozos-Vazquez E; Vidal-Insua Y; Vazquez-Rivera F; Candamio-Folgar S; Mosquera-Presedo M; Lago-Lestón RM; Muinelo-Romay L; Vázquez-Bueno JÁ; Sanz-Pamplona R; Moreno V; Goel A; Castillo L; Martin AC; Arroyo R; Esteller M; Crujeiras AB; López-López R; Díaz-Lagares A
    Clin Epigenetics; 2022 Jul; 14(1):86. PubMed ID: 35810318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas.
    Kim JC; Choi JS; Roh SA; Cho DH; Kim TW; Kim YS
    Ann Surg Oncol; 2010 Jul; 17(7):1767-76. PubMed ID: 20077021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
    Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
    Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis.
    Lind GE; Kleivi K; Meling GI; Teixeira MR; Thiis-Evensen E; Rognum TO; Lothe RA
    Cell Oncol; 2006; 28(5-6):259-72. PubMed ID: 17167179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
    Singh A; Gupta S; Badarukhiya JA; Sachan M
    Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data.
    Kok-Sin T; Mokhtar NM; Ali Hassan NZ; Sagap I; Mohamed Rose I; Harun R; Jamal R
    Oncol Rep; 2015 Jul; 34(1):22-32. PubMed ID: 25997610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disentangling tumorigenesis-associated DNA methylation changes in colorectal tissues from those associated with ageing.
    Orjuela S; Parker HR; Sajibu S; Cereatti F; Sauter M; Buffoli F; Robinson MD; Marra G
    Epigenetics; 2022 Jun; 17(6):677-694. PubMed ID: 34369258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
    Vega-Benedetti AF; Loi E; Moi L; Orrù S; Ziranu P; Pretta A; Lai E; Puzzoni M; Ciccone L; Casadei-Gardini A; Cabras F; Fortunato F; Restivo A; Zorcolo L; Scartozzi M; Zavattari P
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
    Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
    Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors.
    Poeta ML; Massi E; Parrella P; Pellegrini P; De Robertis M; Copetti M; Rabitti C; Perrone G; Muda AO; Molinari F; Zanellato E; Crippa S; Caputo D; Caricato M; Frattini M; Coppola R; Fazio VM
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1133-43. PubMed ID: 22927297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma.
    Kumar A; Gosipatala SB; Pandey A; Singh P
    Asian Pac J Cancer Prev; 2019 May; 20(5):1571-1577. PubMed ID: 31128064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-assessing
    Vedeld HM; Nesbakken A; Lothe RA; Lind GE
    Clin Epigenetics; 2018; 10():70. PubMed ID: 29854011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.